Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dariusz Dąbruś"'
Publikováno v:
Current Pharmaceutical Biotechnology
Background: Semaphorin 3F (SEMA3F) plays a substantial role in carcinogenesis, because of its role in inducing angiogenesis, and creating a microenvironment for the developing tumor. Objective: The purpose of this work was to assess the impact of cis
Autor:
Nikola Zmarzły, Piotr Januszyk, Barbara Tomala, Beniamin Grabarek, Dariusz Boroń, Ryszard Brus, Marcin Oplawski, Dariusz Dąbruś, Konrad Dziobek
Publikováno v:
Current Pharmaceutical Biotechnology
Background:Neuropilins (NRPs) participate in many processes related to cancer development such as angiogenesis, lymphangiogenesis and metastasis. Although endometrial cancer is one of the most common gynecological cancers, it has not been studied in
Autor:
Dariusz Dąbruś, Agnieszka Kuś-Kierach, Beniamin Grabarek, Konrad Dziobek, Nikola Zmarzły, Marcin Oplawski, Piotr Januszyk, Tomasz Halski, Kamil Kiełbasiński, Iwona Adwent, Dariusz Boroń
Publikováno v:
Current Pharmaceutical Biotechnology. 20:1004-1010
Background:Vascular endothelial growth factor (VEGF)-C, -D, and VEGF receptor-3 are proteins characterized as crucial for tumor lymphangiogenesis. It is accompanied by angiogenesis during wound healing, but also in the neoplastic process. The researc
Autor:
Konrad Dziobek, Marcin Oplawski, Ewa Leśniak, Beniamin Grabarek, Iwona Adwent, Dariusz Boroń, Nikola Zmarzły, Barbara Tomala, Piotr Januszyk, Dariusz Dąbruś
Publikováno v:
Current Pharmaceutical Biotechnology
Background:EDIL3 is an extracellular matrix protein that plays a key role in angiogenesis. Changes in the pattern of its expression also affect cellular processes and the tumor microenvironment. Elevated level of EDIL3 is considered an unfavorable pr
Autor:
Ewa Leśniak, Nikola Zmarzły, Robert Kiełbasiński, Piotr Januszyk, Dariusz Boroń, Marcin Oplawski, Beniamin Grabarek, Przemysław Kieszkowski, Konrad Dziobek, Iwona Adwent, Dariusz Dąbruś
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background SEMA3B is known as an inhibitor of angiogenesis and cell proliferation. During carcinogenesis, the loss of SEMA3B function is observed, which results in the progression of neoplastic changes. The aim of this study was to evaluate the expre
Autor:
Konrad Dziobek, Andrzej Plewka, Nikola Zmarzły, Dariusz Dąbruś, Marcin Oplawski, Beniamin Grabarek, Iwona Adwent, Dariusz Boroń
Publikováno v:
Current Pharmaceutical Biotechnology. 19(12):990-995
Background Endoglin is a marker of active, proliferating endothelial cells of blood vessels. In many cancers, it is present in both peripheral vessels and vessels located inside the tumor. Endoglin is more specific and sensitive compared to other tum
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 4135, p 4135 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 11
International Journal of Molecular Sciences
Volume 21
Issue 11
This research aimed to assess the impact of cisplatin, depending on the concentration and exposure time, on the expression pattern of leptin in an endometrial cancer cell line. Ishikawa endometrial cancer cell cultures were incubated with cisplatin,
Autor:
Beniamin Grabarek, Dariusz Boroń, Marcin Oplawski, Przemysław Kieszkowski, Krzysztof Januszyk, Ewa Leśniak, Konrad Dziobek, Nikola Zmarzły, Iwona Adwent, Dariusz Dąbruś, Agnieszka Kuś-Kierach, Ryszard Kiełbasiński, Kamil Kiełbasiński, Piotr Januszyk
Publikováno v:
Current Pharmaceutical Biotechnology
Background: In the course of neoplastic diseases, a reduction in SEMA3F expression is observed, which translates into an increase in the proliferative and proangiogenic potential of cells forming the tumor and the surrounding microenvironment. Object